Project Details
| Short title | PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib |
|---|---|
| Status | Active |
| Effective start/end date | 1/04/22 → 30/06/26 |
Funding
- BeiGene
PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib
- Boucher, Becky (Co-Investigator)
- Jackson, Aimee (Principal Investigator)
- Craddock, Charles (Researcher)